Bessemer Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,156
Closed -$580K 1798
2021
Q2
$580K Buy
3,156
+124
+4% +$22.8K ﹤0.01% 529
2021
Q1
$464K Sell
3,032
-24
-0.8% -$3.67K ﹤0.01% 555
2020
Q4
$478K Buy
3,056
+313
+11% +$49K ﹤0.01% 541
2020
Q3
$313K Sell
2,743
-6,663
-71% -$760K ﹤0.01% 620
2020
Q2
$1.06M Buy
9,406
+9,187
+4,195% +$1.03M ﹤0.01% 758
2020
Q1
$20K Buy
219
+205
+1,464% +$18.7K ﹤0.01% 1365
2019
Q4
$2K Sell
14
-415
-97% -$59.3K ﹤0.01% 1573
2019
Q3
$42K Buy
429
+329
+329% +$32.2K ﹤0.01% 1302
2019
Q2
$13K Sell
100
-776
-89% -$101K ﹤0.01% 1465
2019
Q1
$118K Sell
876
-1,220
-58% -$164K ﹤0.01% 1106
2018
Q4
$203K Sell
2,096
-1,108,319
-100% -$107M ﹤0.01% 976
2018
Q3
$154M Buy
1,110,415
+20,723
+2% +$2.88M 0.57% 63
2018
Q2
$135M Buy
1,089,692
+351,907
+48% +$43.7M 0.52% 70
2018
Q1
$82.2M Buy
737,785
+12,289
+2% +$1.37M 0.32% 106
2017
Q4
$86.8M Sell
725,496
-7,076
-1% -$846K 0.34% 100
2017
Q3
$103M Buy
732,572
+11,168
+2% +$1.57M 0.41% 94
2017
Q2
$87.8M Buy
721,404
+721,367
+1,949,641% +$87.8M 0.35% 96
2017
Q1
$4K Sell
37
-25
-40% -$2.7K ﹤0.01% 1645
2016
Q4
$7K Sell
62
-255
-80% -$28.8K ﹤0.01% 1697
2016
Q3
$39K Sell
317
-417
-57% -$51.3K ﹤0.01% 1241
2016
Q2
$86K Buy
734
+83
+13% +$9.73K ﹤0.01% 790
2016
Q1
$91K Sell
651
-1,307
-67% -$183K ﹤0.01% 801
2015
Q4
$374K Buy
1,958
+475
+32% +$90.7K ﹤0.01% 662
2015
Q3
$232K Buy
1,483
+1,288
+661% +$201K ﹤0.01% 745
2015
Q2
$35K Buy
195
+22
+13% +$3.95K ﹤0.01% 1041
2015
Q1
$30K Sell
173
-280
-62% -$48.6K ﹤0.01% 1070
2014
Q4
$84K Buy
453
+78
+21% +$14.5K ﹤0.01% 836
2014
Q3
$62K Buy
375
+148
+65% +$24.5K ﹤0.01% 839
2014
Q2
$35K Buy
+227
New +$35K ﹤0.01% 929
2013
Q3
Sell
-500
Closed -$46K 1409
2013
Q2
$46K Buy
+500
New +$46K ﹤0.01% 786